Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Irbesartan (150mg) + Metoprolol Succinate (25mg) Tablet
Therapeutic Category
Cardiology, Cardiovascular, Hypertension/ Blood Pressure
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Irbetol M Tablet containing Irbesartan and Metoprolol Succinate is used for the management of hypertension and related cardiovascular conditions. It helps control elevated blood pressure and supports long-term cardiovascular health.
Irbesartan works as an angiotensin II receptor blocker (ARB) that helps relax blood vessels and improve blood flow, while Metoprolol Succinate acts as a beta-blocker that helps reduce heart rate and cardiac workload, contributing to better blood pressure control.
The tablet is widely prescribed in cardiology and general medicine practice for patients requiring combination antihypertensive therapy, leading to consistent prescription demand.
With the increasing prevalence of hypertension and cardiovascular disorders and growing demand for effective combination therapies, this product offers strong business potential for retailers and distributors. Its dual-action formulation, established clinical efficacy, and steady market demand make it a reliable product for growth in the cardiac care segment.
Some patients may experience dizziness, fatigue, headache, slow heart rate, nausea, weakness, low blood pressure, or cold hands and feet. Rarely, severe hypotension, worsening heart failure, allergic reactions, breathing difficulties, or significant cardiac rhythm disturbances may occur and require immediate medical attention.
Irbetol M Tablet is indicated for hypertension (high blood pressure), cardiovascular risk reduction, and other conditions requiring combination antihypertensive therapy as prescribed by a healthcare professional. It helps lower blood pressure, reduce cardiac workload, and decrease the risk of complications such as heart attack, stroke, and kidney damage.
This medicine should be used strictly under medical supervision. Regular monitoring of blood pressure, heart rate, kidney function, and overall cardiovascular status is recommended during treatment. Do not discontinue Metoprolol abruptly, as sudden withdrawal may worsen cardiac symptoms. Use cautiously in patients with asthma, diabetes, kidney disease, liver impairment, or heart conduction disorders.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Glibenclamide I.P. 5mg + Metformin Hydrochloride I.P. 500mg + Pioglitazone Hydrochloride I.P. 15mg Tablets
Composition : Glimepiride (1mg) Tablet
Composition : Glimepiride (2mg) Tablet
Composition : Glimepiride 1mg + Metformin 500mg + Pioglitazone 15mg Bi-Layered Tablets
Composition : Glimepiride 2mg + Metformin Hydrochloride I.P. 500mg + Pioglitazone 15mg Bi-Layered Tablets
Composition : Gliclazide 80mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : LISINOPRIL 5 + AMLODIPINE 5 MG tablet
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.